Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Julphar
Citi
Mallinckrodt
Cipla
Chinese Patent Office
Boehringer Ingelheim
Healthtrust
Daiichi Sankyo

Generated: August 17, 2018

DrugPatentWatch Database Preview

Taro Pharm Inds Company Profile

« Back to Dashboard

What is the competitive landscape for TARO PHARM INDS, and when can generic versions of TARO PHARM INDS drugs launch?

TARO PHARM INDS has thirty-one approved drugs.

There are two US patents protecting TARO PHARM INDS drugs. There is one tentative approval on TARO PHARM INDS drugs.

There are ten patent family members on TARO PHARM INDS drugs in seven countries and nineteen supplementary protection certificates in nine countries.

Summary for Taro Pharm Inds
International Patents:10
US Patents:2
Tradenames:21
Ingredients:19
NDAs:31

Drugs and US Patents for Taro Pharm Inds

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm Inds HYDROCORTISONE BUTYRATE hydrocortisone butyrate SOLUTION;TOPICAL 076364-001 Jan 14, 2004 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Taro Pharm Inds LAMOTRIGINE lamotrigine TABLET;ORAL 078525-004 Jan 27, 2009 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Taro Pharm Inds FLUTICASONE PROPIONATE fluticasone propionate OINTMENT;TOPICAL 077145-001 Jun 14, 2005 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Taro Pharm Inds Ltd HYDROCORTISONE hydrocortisone CREAM;TOPICAL 088799-001 Nov 9, 1984 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Taro Pharm Inds Ltd TOPICORT desoximetasone GEL;TOPICAL 018586-001 Mar 29, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Taro Pharm Inds Ltd FLUOCINONIDE EMULSIFIED BASE fluocinonide CREAM;TOPICAL 072494-001 Jan 19, 1989 AB2 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Taro Pharm Inds AMCINONIDE amcinonide CREAM;TOPICAL 076229-001 May 31, 2002 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for TARO PHARM INDS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Spray 0.25% ➤ Subscribe 2013-12-18
➤ Subscribe Topical Lotion 0.5% ➤ Subscribe 2011-03-16

Non-Orange Book US Patents for Taro Pharm Inds

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,039,657 Process for preparing malathion for pharmaceutical use ➤ Try a Free Trial
8,957,238 Process for preparing malathion for pharmaceutical use ➤ Try a Free Trial
8,536,155 Process for preparing malathion for pharmaceutical use ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Taro Pharm Inds Drugs

Supplementary Protection Certificates for Taro Pharm Inds Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB10/012 United Kingdom ➤ Try a Free Trial PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
1304992/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
C/GB01/012 United Kingdom ➤ Try a Free Trial PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115
C0004 France ➤ Try a Free Trial PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730
C0014 France ➤ Try a Free Trial PRODUCT NAME: FLUTICASONE FLUORATE; REG. NO/DATE: EU/1/07/434/001 20080111
C0067 France ➤ Try a Free Trial PRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215
2013 00053 Denmark ➤ Try a Free Trial PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Fuji
Mallinckrodt
QuintilesIMS
Cipla
Dow
Fish and Richardson
Chubb
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.